Menu Back toSession-0906-Innovative-Approaches-to-Ensuring-Quality-in-Clinical-Trials-and-Compliance-to-GCP

The 7th DIA China Annual Meeting


Session 0906 Innovative Approaches to Ensuring Quality in Clinical Trials and Compliance to GCP

Session Chair(s)

Deborah  Driscoll, MS

Deborah Driscoll, MS

  • Vice President, MRL Quality Assurance
  • Merck & Co., Inc., United States

Trans Celerate Quality Management System Initiative (EN&CN)

Speaker(s)

Ann  Meeker-O'Connell, MS

Ann Meeker-O'Connell, MS

  • Vice President, Integrated QMS/OMS
  • Vertex Pharmaceuticals, United States
Brett  Wilson

Trial-Level Quality approach highlighting TransCelerate’s model approach to RBM (EN&CN).pdf

Brett Wilson

  • Senior Director, Global Biometrics & Data Management
  • Pfizer Inc., Canada
Gongtao  Lan

Gongtao Lan

  • CFDA - Registration, China
Jianan  Wang

Jianan Wang

  • Assistant Pharmacist
  • CCD, CFDA, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650